Atlas Trials

A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.

Clinical trial NCT04225897 · TERMINATED

Trial details

NCT number
NCT04225897
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Respiratory Syncytial Virus (RSV)Lower Resp Tract Infection
Start date
2019-11-13
Primary completion
2022-12-05
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.